checkAd

    Blonder Tongue Laboratories, Inc. - 500 Beiträge pro Seite

    eröffnet am 23.12.05 18:13:56 von
    neuester Beitrag 18.05.06 12:37:52 von
    Beiträge: 9
    ID: 1.028.632
    Aufrufe heute: 0
    Gesamt: 347
    Aktive User: 0

    ISIN: US0936981085 · WKN: 936191 · Symbol: BDRL
    0,1880
     
    USD
    +88,00 %
    +0,0880 USD
    Letzter Kurs 02:10:00 Nasdaq OTC

    Werte aus der Branche Sonstige Technologie

    WertpapierKursPerf. %
    110,53+20,00
    654,00+11,54
    4,0700+10,90
    6,1100+10,89
    7,4200+9,93
    WertpapierKursPerf. %
    0,5550-9,76
    1,9899-11,56
    2,4450-11,73
    2,2025-18,12
    0,9150-30,15

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 23.12.05 18:13:56
      Beitrag Nr. 1 ()
      Profile:Blonder Tongue Laboratories, Inc. engages in the design, manufacture, and supply of electronics and systems equipment for the cable television industry in the United States. The company also offers equipment and solutions for the high-speed transmission of data and the provision of telephony services in multiple dwelling unit applications. It offers analog video headend products, digital video headend products, high-speed data products, telephony products, microwave products, fiber products, distribution products, addressable subscriber and interdiction products, and test products. These products are used to acquire, distribute, and protect a range of communications signals carried on fiber optic, twisted pair, coaxial cable, and wireless distribution systems. The company`s customers comprise cable system integrators, as well as companies engaged in the provision of communications services, including television, high-speed data, and telephony to single family dwellings, multiple dwelling units, the lodging industry, hospitals, prisons, schools, and marinas. Blonder Tongue Laboratories was founded by Ben H. Tongue and Isaac S. Blonder in 1950. The company is headquartered in Old Bridge, New Jersey.

      http://www.blondertongue.com/

      Avatar
      schrieb am 23.12.05 18:15:06
      Beitrag Nr. 2 ()
      Avatar
      schrieb am 23.12.05 20:41:07
      Beitrag Nr. 3 ()
      insider kaufen
      sieht gut aus

      Avatar
      schrieb am 16.05.06 16:04:14
      Beitrag Nr. 4 ()
      gute Quartalszahlen!

      unterbewertet!:lick:

      http://biz.yahoo.com/e/060512/bdr10-q.html


      BDR: Q1 EPS 2c vs (11c) EPS +118% Y/Y

      Friday , May 12, 2006 17:23 ET

      QUARTER RESULTS
      Blonder Tongue Labs, Inc. (BDR) reported Q1 results ended March 2006. Q1 Revenues were $10.39M; +12.08% vs yr-ago. Q1 EPS was 2c; +118.18% vs yr-ago.

      Q1 RESULTS Reported Year-Ago Y/Y Chg Estimate SURPRISE
      ---------- ------------ ------------ ---------- ------------ ----------
      Revenues: $10.39M $9.27M +12.08% N/A N/A
      ---------- ------------ ------------ ---------- ------------ ----------
      EPS: 2c (11c) +118.18% N/A N/A
      ---------- ------------ ------------ ---------- ------------ ----------
      Avatar
      schrieb am 16.05.06 16:05:31
      Beitrag Nr. 5 ()

      Trading Spotlight

      Anzeige
      Nurexone Biologic
      0,4280EUR -0,47 %
      InnoCan startet in eine neue Ära – FDA Zulassung!mehr zur Aktie »
      Avatar
      schrieb am 17.05.06 14:07:32
      Beitrag Nr. 6 ()
      :lick::lick::lick::lick:

      Blonder Tongue Reports 2006 First Quarter Results
      Wednesday May 17, 8:00 am ET


      OLD BRIDGE, N.J.--(BUSINESS WIRE)--May 17, 2006--Blonder Tongue Laboratories, Inc. (AMEX: "BDR") today announced its sales and earnings for the first quarter ended March 31, 2006.
      Net sales for the first quarter 2006 increased 12.1% to $10,387,000 from $9,269,000 for the first quarter 2005. The increase in sales is primarily attributed to an increase in sales of the Company's digital and headend products. Digital product sales were $1,433,000 and $942,000 and headend product sales were $5,050,000 and $4,682,000 in the first quarter of 2006 and 2005, respectively. Operating income for the first quarter 2006 was $437,000 compared to an operating loss of $603,000 for the comparable period of 2005. The improvement in operating income in the first quarter of 2006 was primarily attributed to an increase in sales as compared to the first quarter of 2005. The first quarter operating loss in 2005 was primarily attributable to a $603,000 increase in inventory reserves. Comparatively, no increase in inventory reserves was required in the first quarter of 2006. The Company's net earnings were $192,000 for the first three months of 2006 compared to a net loss of $890,000 for the same period in the prior year. Basic and diluted earnings per share for the first three months of 2006 were $0.02, compared to a loss of $0.11 per share for the same period in the prior year.


      Commenting on the first quarter 2006 results, James A. Luksch, Chairman, Chief Executive Officer said, "I'm pleased to report that the Company has posted profitable performance for the period. First quarter results benefited from an expanded array of product offerings, particularly in the areas of fiber, digital and high definition products. We look forward to continuing long term progress as our new product offerings take hold and provide additional incremental sales."

      Founded in 1950, Blonder Tongue Laboratories, Inc. has evolved from a manufacturer of electronic equipment for the private cable industry to a principal provider of integrated network solutions and technical services to broadband service providers. The Company designs, manufactures, and supplies a comprehensive line of equipment to deliver video (analog & digital), high speed data and voice services over integrated coaxial and fiber optic broadband networks today and over packet based, Internet protocol networks of the future. For more information regarding Blonder Tongue or its products, please visit the Company's Web site at www.blondertongue.com or contact the Company directly at (732) 679-4000.

      "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The information set forth above includes "forward-looking" statements and accordingly, the cautionary statements contained in Blonder Tongue's Annual Report and Form 10-K for the year ended December 31, 2005 (See Item 1: Business, Item 1A: Risk Factors and Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations), and other filings with the Securities and Exchange Commission are incorporated herein by reference. The words "believe", "expect", "anticipate", "project", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. Blonder Tongue undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof. Blonder Tongue's actual results may differ from the anticipated results or other expectations expressed in Blonder Tongue's "forward-looking" statements.

      Blonder Tongue Laboratories, Inc.
      Consolidated Summary of Operating Results
      (in thousands, except per-share data)
      (unaudited)

      Three months ended
      March 31,
      -------------------------
      2006 2005
      -------------------------

      Net Sales $10,387 $9,269
      Gross Profit 3,570 2,527
      Earnings (loss) from operations 437 (603)
      Net earnings (loss) 192 (890)
      Net earnings (loss) per share:
      Basic and diluted $0.02 ($0.11)
      Weighted average shares outstanding:
      Basic and diluted 8,015 8,015



      Consolidated Summary Balance Sheets
      (in thousands)

      March 31, 2006 December 31, 2005
      -------------- -----------------
      (unaudited)

      Current assets $15,519 $15,144
      Property, plant, and equipment, net 6,103 6,184
      Total assets 32,907 32,864
      Current liabilities 7,951 8,036
      Long-term liabilities 3,262 3,329
      Stockholders' equity 21,694 21,499

      Total liabilities and stockholders'
      equity $32,907 $32,864




      Contact:
      Blonder Tongue Laboratories, Inc.
      James A. Luksch, 732-679-4000

      --------------------------------------------------------------------------------
      Source: Blonder Tongue Laboratories, Inc.
      Avatar
      schrieb am 17.05.06 15:38:46
      Beitrag Nr. 7 ()
      :lick:

      ab geht es!:lick:

      nach den heutigen zahlen = unterbewertet!!!!
      Avatar
      schrieb am 17.05.06 15:39:45
      Beitrag Nr. 8 ()
      +14% :lick:
      Avatar
      schrieb am 18.05.06 12:37:52
      Beitrag Nr. 9 ()
      Marcetcap. 16 Millionen$

      Quartalszahlen: 10,39 Millionen$
      Gewinn : 2 cent $

      :lick::lick::lick::lick:

      unterbewertet


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.
      Blonder Tongue Laboratories, Inc.